MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)
Public ClinicalTrials.gov record NCT03230838. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Subjects With Complicated Urinary Tract Infection, Including Pyelonephritis
Study identification
- NCT ID
- NCT03230838
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 134 participants
Conditions and interventions
Interventions
- Ceftolozane/Tazobactam Drug
- Meropenem Drug
Drug
Eligibility (public fields only)
- Age range
- 7 Days to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 25, 2018
- Primary completion
- Dec 2, 2020
- Completion
- Dec 2, 2020
- Last update posted
- May 5, 2023
2018 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital - Los Angeles ( Site 2509) | Los Angeles | California | 90027 | — |
| Children's Hospital of Orange County ( Site 2502) | Orange | California | 92868 | — |
| Rady Children's Hospital-San Diego ( Site 2505) | San Diego | California | 92123 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 2519) | Chicago | Illinois | 60611 | — |
| Our Lady of the Lake Hospital ( Site 2512) | Baton Rouge | Louisiana | 70808 | — |
| St. Louis Children's Hospital ( Site 2508) | St Louis | Missouri | 63110 | — |
| SUNY Upstate Medical University Hospital ( Site 2510) | Syracuse | New York | 13210 | — |
| Wake Forest Baptist Health ( Site 2520) | Winston-Salem | North Carolina | 27157 | — |
| Baylor College Of Medicine ( Site 2515) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03230838, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03230838 live on ClinicalTrials.gov.